Eleven Biotherapeutics, Inc – EBIO Phase 3

Eleven Biotherapeutics, Inc – EBIO has phase 3 preliminary data due May 21, 2018 for:
Non-muscle invasive bladder cancer (NMIBC)

Phase 3 completion of enrollment announced March 12, 2018 with preliminary data due May 21, 2018. 3 month data due mid 2018. 12-month data due mid 2019.

Sharing is Caring:

Author: ZitroStocks

Welcome to ZitroStocks, hope you enjoy your visit. You are welcome to ask questions and participate in discussions.

Leave a Reply

Your email address will not be published. Required fields are marked *

One thought on “Eleven Biotherapeutics, Inc – EBIO Phase 3”